Dare Bioscience Inc (DARE)
0.4161
-0.02
(-4.56%)
USD |
NASDAQ |
May 28, 16:00
0.4049
-0.01
(-2.69%)
After-Hours: 20:00
Dare Bioscience Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.3673M |
| September 30, 2020 | 0.3673M |
| June 30, 2020 | 0.3673M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.6975M |
| September 30, 2016 | 14.74M |
| June 30, 2016 | 16.67M |
| March 31, 2016 | 18.52M |
| December 31, 2015 | 20.32M |
| September 30, 2015 | 14.56M |
| June 30, 2015 | 14.49M |
| March 31, 2015 | 14.41M |
| December 31, 2014 | 3.124M |
| September 30, 2014 | 3.934M |
| June 30, 2014 | 4.725M |
| March 31, 2014 | 22.82M |
| December 31, 2013 | 15.08M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
0.3673M
Maximum
Jun 2020
0.0551M
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
| Altimmune Inc | 0.00 |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Orgenesis Inc | 26.00M |